SSXB9 inhibitors represent a class of molecules specifically designed to interact with and modulate the activity of the SSXB9 protein, a critical regulator involved in various cellular processes. These inhibitors typically work by binding to the active site or allosteric regions of SSXB9, interfering with its normal function and thus influencing the biochemical pathways in which SSXB9 is a key participant. The design and synthesis of SSXB9 inhibitors involve detailed knowledge of the protein's structure, including its binding pockets, which often require high-resolution crystallographic data or computational modeling. The chemical diversity of SSXB9 inhibitors is broad, ranging from small organic molecules to larger, more complex entities, such as peptides or modified nucleotides, depending on the specific binding mechanism. The inhibitors are tailored to achieve high specificity, minimizing interactions with other proteins to ensure selective inhibition of SSXB9. This specificity is achieved through optimizing molecular features such as hydrophobicity, hydrogen-bonding capabilities, and molecular conformation, all designed to complement the structure of SSXB9.
From a chemical standpoint, the development of SSXB9 inhibitors requires rigorous synthetic chemistry techniques to create novel scaffolds or modify existing ones for enhanced potency and selectivity. These scaffolds often incorporate a variety of functional groups that participate in key non-covalent interactions with the protein, such as hydrogen bonds, Van der Waals forces, and π-π stacking interactions. Researchers also examine the stability, solubility, and bioavailability of these inhibitors, ensuring they maintain their structural integrity under various experimental conditions. Advanced techniques such as structure-activity relationship (SAR) studies are employed to optimize these inhibitors by systematically altering different chemical moieties to improve binding affinity and selectivity. This iterative process is critical in fine-tuning the inhibitors' properties, making them powerful tools in understanding the precise biological role of SSXB9 within different molecular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to inhibit the expression of SSX member B9 by downregulating its transcriptional activity through various signaling pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol exhibits inhibitory effects on SSX member B9 expression by modulating key molecular pathways involved in its regulation, such as inhibition of certain transcription factors or induction of apoptosis. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can suppress the expression of SSX member B9 by interfering with its transcriptional machinery or through direct inhibition of protein-protein interactions critical for its function. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine inhibits the expression of SSX member B9 potentially by modulating the activity of transcription factors involved in its regulation or by disrupting its interaction with other cellular components necessary for its function. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin may inhibit the expression of SSX member B9 by interfering with its mRNA stability, thus reducing its overall levels within the cell. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein can downregulate SSX member B9 expression by modulating the activity of various signaling pathways involved in its transcriptional regulation, thereby reducing its overall abundance in the cell. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin inhibits SSX member B9 expression by interfering with its transcriptional activity or by promoting its degradation through the ubiquitin-proteasome system. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane may inhibit SSX member B9 expression by altering the epigenetic landscape of its gene locus, leading to decreased transcriptional activity or stability of its mRNA transcripts. | ||||||
Gallic acid | 149-91-7 | sc-205704 sc-205704A sc-205704B | 10 g 100 g 500 g | $56.00 $87.00 $245.00 | 14 | |
Gallic acid can inhibit SSX member B9 expression by interfering with the function of key transcription factors or by modulating chromatin structure at its gene locus, resulting in reduced transcriptional activity. | ||||||
Silybin | 22888-70-6 | sc-202812 sc-202812A sc-202812B sc-202812C | 1 g 5 g 10 g 50 g | $55.00 $114.00 $206.00 $714.00 | 6 | |
Silibinin inhibits SSX member B9 expression potentially by interfering with its post-translational modification or by disrupting its interaction with other cellular components critical for its stability or function. | ||||||